KEYNOTE-028 Trial Unveils Biomarkers Linked to Pembrolizumab Efficacy

The results of the study add to the growing body of literature regarding potential biomarkers for response to immune checkpoint inhibitors.

Source: Cancer Network - January 16, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news